Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Cash from Financing Activities (2017 - 2025)

Historic Cash from Financing Activities for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $2.4 million.

  • Catheter Precision's Cash from Financing Activities fell 3910.45% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 13356.27%. This contributed to the annual value of $8.6 million for FY2024, which is 310.04% up from last year.
  • According to the latest figures from Q3 2025, Catheter Precision's Cash from Financing Activities is $2.4 million, which was down 3910.45% from $2.7 million recorded in Q2 2025.
  • Catheter Precision's 5-year Cash from Financing Activities high stood at $11.2 million for Q1 2022, and its period low was -$516000.0 during Q2 2022.
  • Its 5-year average for Cash from Financing Activities is $3.4 million, with a median of $2.6 million in 2025.
  • As far as peak fluctuations go, Catheter Precision's Cash from Financing Activities plummeted by 11447.37% in 2021, and later surged by 695644.17% in 2022.
  • Quarter analysis of 5 years shows Catheter Precision's Cash from Financing Activities stood at $141000.0 in 2021, then surged by 3592.2% to $5.2 million in 2022, then crashed by 102.06% to -$107000.0 in 2023, then skyrocketed by 4276.64% to $4.5 million in 2024, then plummeted by 45.22% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $2.7 million for Q2 2025, and -$75000.0 during Q1 2025.